Ranbaxy CEO Arun Sawhney On “Thrilling” Days Of Atorvastatin Approvals – An Exclusive Interview With PharmAsia News (Part 1 of 2)

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.